: Most-Read Full-Text Articles http://jnnp.bmj.com Most-read rankings are recalculated at the beginning of the month based on usage of full-text and PDF views for the previous month. 2026-06-08 <![CDATA[Lecanemab appropriate use recommendations for clinical practice in the UK]]> http://jnnp.bmj.com/cgi/content/short/jnnp;97/5/372?rss=1&ssource=mfr May 1, 2026; 97:372-384
Neurodegeneration]]> Catherine J Mummery 2026-05-01 10.1136/jnnp-2025-336597 BMJ Publishing Group Ltd 5 97 384 2026-05-01 Neurodegeneration 372 <![CDATA[Discontinuation of ocrelizumab in multiple sclerosis: reoccurrence of disease activity]]> http://jnnp.bmj.com/cgi/content/short/jnnp;97/6/513?rss=1&ssource=mfr Jun 1, 2026; 97:513-521
Multiple sclerosis]]> Franz Felix Konen 2026-06-01 10.1136/jnnp-2025-337944 BMJ Publishing Group Ltd 6 97 521 2026-06-01 Multiple sclerosis 513 <![CDATA[Evaluation of metformin for epilepsy prevention or seizure control in people without evidence of diabetes: retrospective cohort study]]> http://jnnp.bmj.com/cgi/content/short/jnnp;jnnp-2025-337861v1?rss=1&ssource=mfr May 13, 2026; 0:jnnp-2025-337861v1-jnnp-2025-337861
Epilepsy]]> Gashirai K Mbizvo 2026-05-13 10.1136/jnnp-2025-337861 BMJ Publishing Group Ltd 2026 0 jnnp-2025-337861 2026-05-13 Epilepsy jnnp-2025-337861v1 <![CDATA[Intravenous methylprednisolone as add-on induction therapy for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial]]> http://jnnp.bmj.com/cgi/content/short/jnnp;97/6/558?rss=1&ssource=mfr Jun 1, 2026; 97:558-566
Neuromuscular]]> Sander R M Bus 2026-06-01 10.1136/jnnp-2025-338140 BMJ Publishing Group Ltd 6 97 566 2026-06-01 Neuromuscular 558 <![CDATA[Adherence to the MIND diet and longitudinal brain structural changes over a decade: evidence from the Framingham heart study offspring cohort]]> http://jnnp.bmj.com/cgi/content/short/jnnp;97/6/505?rss=1&ssource=mfr Jun 1, 2026; 97:505-512
Cognition]]> Hui Chen 2026-06-01 10.1136/jnnp-2025-336957 BMJ Publishing Group Ltd 6 97 512 2026-06-01 Cognition 505 <![CDATA[Adrenoleukodystrophy in adults: phenotypic characterisation and natural history in a large cohort]]> http://jnnp.bmj.com/cgi/content/short/jnnp;97/6/483?rss=1&ssource=mfr Jun 1, 2026; 97:483-492
Neurogenetics]]> Chiara Benzoni 2026-06-01 10.1136/jnnp-2025-337540 BMJ Publishing Group Ltd 6 97 492 2026-06-01 Neurogenetics 483 <![CDATA[Timing of high-dose folic acid supplementation in the periconceptional period among women taking antiseizure medications and risk of major congenital anomalies: a target trial emulation]]> http://jnnp.bmj.com/cgi/content/short/jnnp;97/6/542?rss=1&ssource=mfr Jun 1, 2026; 97:542-552
Epilepsy]]> Yuelian Sun 2026-06-01 10.1136/jnnp-2025-337395 BMJ Publishing Group Ltd 6 97 552 2026-06-01 Epilepsy 542 <![CDATA[Global burden of disease study highlights the global, regional and national trends of stroke]]> http://jnnp.bmj.com/cgi/content/short/jnnp;97/1/13?rss=1&ssource=mfr Jan 1, 2026; 97:13-24
Cerebrovascular disease]]> Sha Yang 2026-01-01 10.1136/jnnp-2025-335954 BMJ Publishing Group Ltd 1 97 24 2026-01-01 Cerebrovascular disease 13 <![CDATA[Glucagon-like peptide-1 receptor agonists for major neurocognitive disorders]]> http://jnnp.bmj.com/cgi/content/short/jnnp;96/9/870?rss=1&ssource=mfr Sep 1, 2025; 96:870-883
Neurodegeneration]]> Riccardo De Giorgi 2025-09-01 10.1136/jnnp-2024-335593 BMJ Publishing Group Ltd 9 96 883 2025-09-01 Neurodegeneration 870 <![CDATA[Predictors of B-cell repopulation in people with multiple sclerosis treated with ocrelizumab: insights from two large cohorts]]> http://jnnp.bmj.com/cgi/content/short/jnnp;jnnp-2026-338533v1?rss=1&ssource=mfr May 8, 2026; 0:jnnp-2026-338533v1-jnnp-2026-338533
Multiple sclerosis]]> Laura Hogenboom 2026-05-08 10.1136/jnnp-2026-338533 BMJ Publishing Group Ltd 2026 0 jnnp-2026-338533 2026-05-08 Multiple sclerosis jnnp-2026-338533v1